Date | Insider | Price | Amount |
---|---|---|---|
8-10-2020 Insider Buy |
Cynthia Hiskes Chief Human Resources Officer |
$21.00 CAGR » |
$2,520.00 120 shares |
8-10-2020 Insider Buy |
Robert Guenthner Chief Legal Officer |
$21.00 CAGR » |
$42,000.00 2,000 shares |
8-10-2020 Insider Buy |
Paul B. K. Kusserow Director |
$21.00 CAGR » |
$110,460.00 5,260 shares |
8-10-2020 Insider Buy |
Tamara Jurgenson Chief Growth Officer |
$21.00 CAGR » |
$157,500.00 7,500 shares |
Also See: Institutional Holders of OSH
Also See: SEC filings
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 08/11/2020 | |
End date: | 05/01/2023 | |
Start price/share: | $44.57 | |
End price/share: | $39.00 | |
Dividends collected/share: | $0.00 | |
Total return: | -12.50% | |
Average Annual Total Return: | -4.79% | |
Starting investment: | $10,000.00 | |
Ending investment: | $8,749.94 | |
Years: | 2.72 |
Oak Street Health Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent Oak Street Health insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding OSH
Free OSH Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Other companies seeing insider buying close in time to when the Oak Street Health Insider Buying occurred are:
Tenax Therapeutics Insider Buying |